Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression

por Verstovsek, Srdan
Publicado 2013

How I manage anemia related to myelofibrosis and its treatment regimens

por Verstovsek, Srdan
Publicado 2023

Clinical development and management of adverse events associated with FGFR inhibitors

por Subbiah, Vivek, Verstovsek, Srdan
Publicado 2023

Ruxolitinib for essential thrombocythemia?

por Bose, Prithviraj, Verstovsek, Srdan
Publicado 2017

Updates in the management of polycythemia vera and essential thrombocythemia

por Bose, Prithviraj, Verstovsek, Srdan
Publicado 2019

JAK Inhibition for the Treatment of Myelofibrosis: Limitations and Future Perspectives

por Bose, Prithviraj, Verstovsek, Srdan
Publicado 2020

MF management

por Bose, Prithviraj, Verstovsek, Srdan
Publicado 2019

Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib

por Mascarenhas, J, Mughal, TI, Verstovsek, S
Publicado 2012

Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms

por Yacoub, A., Odenike, O., Verstovsek, S.
Publicado 2014

Overcoming treatment challenges in myelofibrosis and polycythemia vera: the role of ruxolitinib

por Bryan, Jeffrey C., Verstovsek, Srdan
Publicado 2016

The clinical dilemma of JAK inhibitor failure in myelofibrosis: Predictive characteristics and outcomes

por Mascarenhas, John O., Verstovsek, Srdan
Publicado 2022

Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments

por Chifotides, Helen T., Verstovsek, Srdan, Bose, Prithviraj
Publicado 2023

Ruxolitinib for the treatment of myelofibrosis: its clinical potential

por Ostojic, Alen, Vrhovac, Radovan, Verstovsek, Srdan
Publicado 2012

Novel Concepts of Treatment for Patients with Myelofibrosis and Related Neoplasms

por Bose, Prithviraj, Masarova, Lucia, Verstovsek, Srdan
Publicado 2020

Momelotinib: an emerging treatment for myelofibrosis patients with anemia

por Chifotides, Helen T., Bose, Prithviraj, Verstovsek, Srdan
Publicado 2022

Ruxolitinib: a targeted treatment option for patients with polycythemia vera

por Vaddi, Kris, Verstovsek, Srdan, Kiladjian, Jean-Jacques
Publicado 2016

PB2232: A RANDOMIZED, CONTROLLED CLINICAL TRIAL (PHASE 2B) OF NS-018 VERSUS BEST AVAILABLE THERAPY IN SUBJECTS WITH PRIMARY OR SECONDARY MYELOFIBROSIS WITH SEVERE THROMBOCYTOPENIA

por Palacio, Melisa, Verstovsek, Srdan, Uno, Tomonori, Yamashita, Taishi
Publicado 2023

Targeting cistrome and dysregulated transcriptome of post-MPN sAML

por Verstovsek, Srdan, Fiskus, Warren, Manshouri, Taghi, Bhalla, Kapil N.
Publicado 2017

Cerebral Sinus Thrombosis: A Fatal Neurological Complication of Ulcerative Colitis

por Nudelman, Rodolfo Jose, Rosen, Daniel Gustavo, Rouah, Emilie, Verstovsek, Gordana
Publicado 2010

Correlation of Tissue Biopsy and Fine Needle Aspiration Cytology with Positron Emission Tomography Results

por Rosen, Daniel, Herrington, Bruce, Bhargava, Peeyush, Laucirica, Rodolfo, Verstovsek, Gordana
Publicado 2011